These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 18308239)
1. Oral treatment for gastric cancer: new choices, better choices? Cascinu S Lancet Oncol; 2008 Mar; 9(3):188-9. PubMed ID: 18308239 [No Abstract] [Full Text] [Related]
2. Oral fluoropyrimidines in colorectal cancer. Van Cutsem E; Peeters M Semin Oncol; 2000 Oct; 27(5 Suppl 10):91-5. PubMed ID: 11049039 [No Abstract] [Full Text] [Related]
3. A comprehensive review of S-1 in the treatment of advanced gastric adenocarcinoma. Blum M; Suzuki A; Ajani JA Future Oncol; 2011 Jun; 7(6):715-26. PubMed ID: 21675835 [TBL] [Abstract][Full Text] [Related]
4. S-1-based chemotherapy versus capecitabine-based chemotherapy as first-line treatment for advanced gastric carcinoma: a meta-analysis. He MM; Wu WJ; Wang F; Wang ZQ; Zhang DS; Luo HY; Qiu MZ; Wang FH; Ren C; Zeng ZL; Xu RH PLoS One; 2013; 8(12):e82798. PubMed ID: 24349363 [TBL] [Abstract][Full Text] [Related]
5. Other fluorinated pyrimidines in the treatment of solid tumors. Saad ED; Hoff PM Oncology (Williston Park); 2001 Jan; 15(1 Suppl 2):65-8. PubMed ID: 11219980 [TBL] [Abstract][Full Text] [Related]
6. Treatment of gastric cancer in Asia: the missing link. Nishida T Lancet Oncol; 2009 Nov; 10(11):1027-8. PubMed ID: 19880057 [No Abstract] [Full Text] [Related]
7. Just when you thought the fluorouracil debate was over: S-1 and gastric cancer. Ilson D J Clin Oncol; 2005 Oct; 23(28):6826-8. PubMed ID: 16145059 [No Abstract] [Full Text] [Related]
13. [The choice of treatment in advanced gastric cancer]. Pozzo C; Mansueto G Tumori; 2007; 93(6):suppl 11-21. PubMed ID: 18338512 [No Abstract] [Full Text] [Related]
14. Phase II study of S-1, a novel oral derivative of 5-fluorouracil, in advanced gastric cancer. For the S-1 Cooperative Gastric Cancer Study Group. Koizumi W; Kurihara M; Nakano S; Hasegawa K Oncology; 2000 Apr; 58(3):191-7. PubMed ID: 10765119 [TBL] [Abstract][Full Text] [Related]
15. [A case of advanced gastric cancer with histological complete response after S-1 chemotherapy]. Yahara N; Hayashi H; Furuya T; Saeki T; Hayashi H; Inoue Y; Yanai H; Ishigaki N Gan To Kagaku Ryoho; 2009 Nov; 36(12):2300-2. PubMed ID: 20037402 [TBL] [Abstract][Full Text] [Related]
16. Rapid development of S-1 in the west for therapy of advanced gastric carcinoma. Ajani JA Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():117-20. PubMed ID: 16897985 [TBL] [Abstract][Full Text] [Related]
17. [Oral fluoropyrimidines in the treatment of colorectal carcinoma]. Porschen R Dtsch Med Wochenschr; 2003 Jun; 128 Suppl 2():S121-3. PubMed ID: 12817344 [No Abstract] [Full Text] [Related]
18. Current topics of S-1 at the 74th Japanese Gastric Cancer Congress. Sasaki T Gastric Cancer; 2003; 6 Suppl 1():9-12. PubMed ID: 12775013 [TBL] [Abstract][Full Text] [Related]
19. New advances in the treatment of gastric cancer. Ilson DH J Natl Compr Canc Netw; 2004 Sep; 2 Suppl 3():S-29-33. PubMed ID: 23570096 [No Abstract] [Full Text] [Related]
20. [Alternate-day oral therapy with S-1 for adjuvant chemotherapy of gastric cancer]. Takebayashi K; Kawai Y; Tagi T; Matsumura M; Shimizu K; Yamamoto H; Mekata E; Tani T; Sato M Gan To Kagaku Ryoho; 2012 Mar; 39(3):385-7. PubMed ID: 22421764 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]